Valproic Acid

Product NDC: 17856-0792
11-digit product format: 178560792
Labeler code: 17856
Product ID: 17856-0792_ecfe5102-f404-416a-a0c1-a798f9446642
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Valproic Acid
Dosage form: SOLUTION
Route: ORAL
Labeler: Atlantic Biologicals Corps
Application: ANDA074060
Marketing category: ANDA
Marketing start: 1995-01-13
Marketing end: 0000-00-00
Substance: VALPROIC ACID
Active strength: 250 mg/5mL
Pharmacologic classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	17856-0792		I	Inactivated by FDA	2026-08-17
excluded package	package	17856-0792	17856-0792-2	D	Discontinued by firm	2026-08-17
excluded package	package	17856-0792	17856-0792-6	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 39 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0792-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0792-6	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0792-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0792-6	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0792-2	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0792-6	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0792-2	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0792-6	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0792-2	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0792-6	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0792-2	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0792-6	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0792-2	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0792-6	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0792-2	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0792-6	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0792-2	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0792-6	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0792-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	17856-0792-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0792-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	17856-0792-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0792-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	17856-0792-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	17856-0792-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	17856-0792-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	17856-0792-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	17856-0792-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	17856-0792-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	17856-0792-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	17856-0792-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	17856-0792-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074060-001	VALPROIC ACID	VALPROIC ACID	250MG/5ML	SYRUP / ORAL			1995-01-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL		1995-01-13	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A074060-001	VALPROIC ACID	250MG/5ML	SYRUP / ORAL	AA	1995-01-13	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074060-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074060-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074060-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074060-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074060-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074060-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A074060-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A074060-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A074060-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A074060-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A074060-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A074060-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A074060-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A074060-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A074060-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A074060-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A074060-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A074060-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A074060-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A074060-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A074060-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A074060-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A074060-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A074060-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A074060-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A074060-001	AA	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b10a892b-b985-4cbc-9547-9ac4b72b784f	Product name	2	20250818
7a3a03f1-382a-f9ec-0741-ff24dcbfed69	Product name	7	20250624
57fc3d01-4737-4091-9728-9e8a4c9e708d	Product name	1	20200121
5d67ecc7-47c7-ec5e-e9eb-71bf00250645	Product name	1	20140508
97fce1a8-50c4-f088-0e31-64d82b6e9081	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0792-2	2026-01-29	Valproic Acid Oral Solution, USP
17856-0792-6	2026-01-29	Valproic Acid Oral Solution, USP
17856-0792-1	2023-02-02	Valproic Acid Oral Solution, USP
17856-0792-5	2023-02-02	Valproic Acid Oral Solution, USP
17856-0792-1	2020-01-31	Valproic Acid Oral Solution, USP
17856-0792-5	2020-01-31	Valproic Acid Oral Solution, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0792-1	Valproic Acid	10 mL in 1 CUP	SOLUTION	10	6
17856-0792-2	Valproic Acid	72 in 1 BOX, UNIT-DOSE	SOLUTION	72	6
17856-0792-5	Valproic Acid	5 mL in 1 CUP	SOLUTION	5	6
17856-0792-6	Valproic Acid	72 in 1 BOX, UNIT-DOSE	SOLUTION	72	6

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
VALPROIC ACID	ACTIVE INGREDIENT	614OI1Z5WI	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
VALPROIC ACID	ACTIVE MOIETY	614OI1Z5WI	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
RASPBERRY	INACTIVE INGREDIENT	4N14V5R27W	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
SORBITOL	INACTIVE INGREDIENT	506T60A25R	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORPS]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0792	VALPROIC ACID SOLUTION [ATLANTIC BIOLOGICALS CORP.]	6	Legacy NDC, 4 package rows	20240517_dce4388c-d663-4829-afa2-2329f0172245.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
614OI1Z5WI	VALPROIC ACID	99-66-1	VALPROIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1099687	valproic acid 250 MG in 5 mL Oral Solution	PSN	dce4388c-d663-4829-afa2-2329f0172245	6
1099687	valproic acid 50 MG/ML Oral Solution	SCD	dce4388c-d663-4829-afa2-2329f0172245	6
1099687	valproate sodium 50 MG/ML Syrup	SY	dce4388c-d663-4829-afa2-2329f0172245	6
1099687	valproic acid 250 MG per 5 ML Oral Solution	SY	dce4388c-d663-4829-afa2-2329f0172245	6
1099687	valproic acid 500 MG per 10 ML Oral Solution	SY	dce4388c-d663-4829-afa2-2329f0172245	6
1099687	VPA 50 MG/ML Oral Solution	SY	dce4388c-d663-4829-afa2-2329f0172245	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
17856-0792-1	17856079201	10 mL in 1 CUP	10 ml	Historical
17856-0792-2	17856079202	72 in 1 BOX, UNIT-DOSE		Historical
17856-0792-5	17856079205	5 mL in 1 CUP	5 ml	Historical
17856-0792-6	17856079206	72 in 1 BOX, UNIT-DOSE		Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Valproic Acid Oral Solution, USP	ATLANTIC BIOLOGICALS CORP.	2024-05-16	HUMAN PRESCRIPTION DRUG LABEL	6